Zymeworks Announces Participation in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Nov 24, 2025
VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME) a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences:
Read more at globenewswire.com25.1
-0.93 (-3.57%)
Find more stocks in the Stock Screener
ZYME Latest News and Analysis
